|
|
||||||||
Institute for Environmental Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-6068
Submitted 22 August 2003 ; accepted in final form 27 January 2004
1-Cys peroxiredoxin (1-cysPrx) is a novel antioxidant enzyme that has been shown to reduce a broad spectrum of peroxides including phospholipid hydroperoxides. We tested the hypothesis that adenovirus-mediated transfer of the 1-cysPrx gene can protect lungs of mice from oxidant injury. Mice infected with AdLacZ/AdNull were used as a control (AdCon). X-galactosidase staining revealed widespread expression of the LacZ gene in airways and lung alveoli. Compared with AdCon, 1-cysPrx expression was increased about twofold at 3 days after adenovirus infection. Mice with increased Prx expression showed less loss of body weight and longer survival during exposure to 100% O2 or to 85% O2 for 4 days followed by 100% O2. At 72 h of 100% O2 exposure, AdPrx infection protected mouse lungs from injury as indicated by less pleural effusion, lower lung wet/dry weight, less protein and fewer nucleated cells in bronchoalveolar lavage fluid, and lower content of thiobarbituric acid-reactive substances and protein carbonyls in lung homogenate. These findings show that increased expression of 1-cysPrx through adenovirus-mediated gene transfer protects mouse lungs from hyperoxic injury and delays death.
peroxiredoxin 6; LacZ gene; protein carbonyls; thiobarbituric acid-reactive substances; gene therapy; bronchoalveolar lavage fluid
This article has been cited by other articles:
![]() |
L. Sun, R.-F. Guo, H. Gao, J. V. Sarma, F. S. Zetoune, and P. A. Ward Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells FASEB J, November 1, 2009; 23(11): 3808 - 3818. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Kim, H.-Y. Jo, M. H. Kim, Y.-y. Cha, S. W. Choi, J.-H. Shim, T. J. Kim, and K.-Y. Lee H2O2-dependent Hyperoxidation of Peroxiredoxin 6 (Prdx6) Plays a Role in Cellular Toxicity via Up-regulation of iPLA2 Activity J. Biol. Chem., November 28, 2008; 283(48): 33563 - 33568. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kumin, M. Schafer, N. Epp, P. Bugnon, C. Born-Berclaz, A. Oxenius, A. Klippel, W. Bloch, and S. Werner Peroxiredoxin 6 is required for blood vessel integrity in wounded skin J. Cell Biol., November 19, 2007; 179(4): 747 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nagy, G. Malik, A. B. Fisher, and D. K. Das Targeted disruption of peroxiredoxin 6 gene renders the heart vulnerable to ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2636 - H2640. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, S. A. Phelan, Y. Manevich, S. I. Feinstein, and A. B. Fisher Transgenic Mice Overexpressing Peroxiredoxin 6 Show Increased Resistance to Lung Injury in Hyperoxia Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 481 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Lehtonen, P. M. H. Markkanen, M. Peltoniemi, S. W. Kang, and V. L. Kinnula Variable overoxidation of peroxiredoxins in human lung cells in severe oxidative stress Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L997 - L1001. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |